Erythropoietin Drugs Market Outlook : A Forecast of the Market Share, and Trends

Market Overview

Also known as hematopoietin, erythropoietin drug is defined as a glycoprotein hormone that controls erythropoiesis. Erythropoiesis is defined as the production of red blood cells (RBC). A new report on the global erythropoietin drug market share is projected to grow at a CAGR of 11.2% during the forecast period 2023-2032.

The most significant market driving factor for the global erythropoietin drug market growth is the increasing prevalence of diseases like cancer and various renal diseases. The increasing investment in medical research & development (R&D) and introduction of new drugs are also carrying forward the market growth. Noth just new drugs but the market is also getting strong due to the introduction of several new erythropoietin drug combinations. Other factors contributing to the global erythropoietin drug market growth include different government initiatives for research and a wider pool of patients being covered due to the introduction of new drug combinations.

Key Players

the global erythropoietin drug market players are 3SBio (China), Amgen (USA), Biocon (India), Biosidus (Argentina), Boehringer Ingelheim (USA), Celltrion Inc. (South Korea), Dahua Pharmaceutical (China), Emcure Pharmaceuticals (India), Hoffmann-La Roche (Switzerland), Hospira (USA), Intas Pharmaceuticals (India), Johnson & Johnson (USA), Kyowa Hakko Kirin (Japan), LG Life Sciences Ltd. (South Korea), and Teva Pharmaceutical Industries Ltd. (Israel).

Market Segmentation

The global erythropoietin drug market outlook encompasses application, end-user, and product type. MRFR’s take on the market surveys various facets of the market in-depth.

The application-based segmentation of this market covers the Human Immunodeficiency Virus (HIV), oncology, renal diseases, and others. In the context of end-user, the market has been segmented into hospital and pharmacy. Regarding product type, the market has been segmented into biosimilars, first-generation formulation, and second-generation formulation.

Regional Segmentation

A geographical outlining of the global erythropoietin drug market covers North America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

North America holds the largest share in the global market due to continuously increasing number of the cancer patient, technological advancement in the medical sector, availability of advanced medical services, governmental initiatives for research, and patient suffering from renal diseases in North America. USA and Canada generate maximum market revenue in this region. Some of the key market players are based in the USA.

In Europe, the market is growing primarily due to the same reasons as in North America. Amendments in reimbursement policies and the growing healthcare sector are also contributing to the market growth. Due to the availability of advanced medical facilities, Western Europe is a bigger regional market than Eastern Europe. The most powerful country-specific markets in Europe are France, Germany, Italy, Spain, and the UK. An inspection of the remaining countries in Western Europe featured in this report speculate the huge contribution to market revenue from some other countries in this region with a sizable revenue from Eastern Europe too.

During the forecast period, the gains for Asia Pacific market can rise high, making it the fastest-growing regional market. The factors benefitting the market growth in this region are increased penetration of healthcare services and expanding patient population in countries like China and India. Moreover, the increased government effort to improve healthcare in these countries is creating new growth opportunities for the market. Other important country-specific markets in this region are Australia, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report estimates the huge contribution to market revenue from some other countries.

The MEA region holds the lowest share in the global market due to poor medical facilities and lack of skilled professionals.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Contraceptive Pills Market Insights Overview, Industry Analysis and Forecasts Report 2032

 

Market Synopsis:

According to the report, the Contraceptive Pills Market Size was valued at USD 20.9 billion in 2022 and is projected to grow from USD 21.4 Billion in 2023 to USD 25.38 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.2% during the forecast period (2023 - 2032).

Contraceptive pills are likely to witness considerable demand in the years to come. The observation offered by Market Research Future (MRFR) unfolds that the global Contraceptive Pills Market Insights is expected to enter a phase of maturity in the foreseeable future.

The issue of problem explosion has encouraged the increasing consumption of contraceptive pills. It has motivated the governments to invest in its distribution for market penetration. In addition, non-profit organizations are also expected to support the use of pills. These factors are expected to expedite the revenue growth of the contraceptive pills market in the years to come. The social awakening regarding the use of these pills supported by organizations is expected to lead the growth of the market in the forthcoming years.

The ongoing protest against abortion has escalated serious concerns regarding accidental pregnancies. This, in turn, is projected to shed light on the pills as a safer option, thus, supporting its increased sales. Also, the easier access to the product is likely to catapult the contraceptive pills market on upward trajectory. However, the availability of alternatives such as condom is expected to check the expansion of the contraceptive pills market over the next couple of years. Increasing awareness about the availability of alternatives is poised to restrict the market growth in the years to come.

Contraceptive pills cause several side effects such as a change in gynecological issues, hormonal imbalance, etc. Some of these pills, especially emergency contraceptive pills, can adversely affect the fecundity of women. This, in turn, is projected to check the expansion of the contraceptive pills market over the next few years. However, the research & development of male contraceptive pills is likely to have a positive impact on market growth in the forthcoming years.

Contraceptive Pills Market Overview and Size, Trends and Growth Outlook by Type [Oral Contraceptives (Combined Oral Contraceptive Pills and Progestogen-Only Pills), Topical Contraceptives, Contraceptive Injectables and others], Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa)

 

Competitive Dashboard:

Pharmaceuticals,

HLL Life Care,

Sopharma AD,

V Care Pharma, and

Ferring B.V

are some of the Contraceptive Pills Market Players. These players are expected to contribute significantly to the expansion of the market in the years to come.

Market Segmentation:

This MRFR report includes a detailed segmental analysis of the global Contraceptive Pills Market Trends based on drug class. The segments of the market include monophasic, triphasic, and others.

Study objectives of Contraceptive Pills Market:

• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Contraceptive Pills market  
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by drug class, and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Contraceptive Pills market.

Regional Analysis:

The report presents an exhaustive regional assessment of the global Contraceptive Pills Market Outlook for offering an informative insight. These segments, on the basis of region, are Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific. Americas is the leading the expansion of the global market and is anticipated to maintain its control over the maximum market share in the foreseeable future. The latest regulations in some of the states of the U.S. against abortion is anticipated to boost the sales of contraceptive in the years to come.

Europe contraceptive pills market is also projected to exhibit considerable growth at the second spot in the upcoming years. Increasing awareness about the product is the key factor responsible for catalyzing expansion of the contraceptive pills in the market over the assessment period. Meanwhile, Asia Pacific is likely to register the highest CAGR across the forecast period.

The market scenario represents healthy competition. Increasing investments in research & development by the key players are poised to boost revenue creation in the contraceptive pills market in the forthcoming years. The emphasis is on the minimization of adverse effects of the pills and ensuring cent percent results. Product development is likely to drive the growth of the contraceptive pills market over the next couple of years. In addition, other growth trajectories are also being trodden by the market participants for acceleration of revenue growth. Some of these growth strategies are mergers & acquisitions, partnerships, collaborations, etc.

Related Reports-

Dental Surgical Devices Market Research Report- Global Forecast till 2030

Hearing Aids Market Research Report - Forecast till 2030

Flow Cytometry Market Research Report –Forecast to 2030

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Vascular Patches Market Insights, Growth Analysis, CAGR Status & forecast to 2032

 

Market Analysis

The global vascular patches market size is poised to touch at a notable 8.0% CAGR over the predicted years 2023-2032. Vascular patches are utilized in vascular surgeries for closing sutures. In every surgical procedure, the primary closure of sutures needs to be done effectively. Vascular patches are made from synthetic or biological materials and are characterized through excellent biocompatibility. Of the different types, it is the biological vascular patches that are most widely used owing to its various advantages such as excellent biocompatibility, low suture line bleeding, minimum infection rate and ease in use.

There are plentiful factors that is boosting the growth of the vascular patches market. These factors as per the Market Research Future (MRFR) report include rapidly increasing geriatric population, prevalence of vascular diseases, growing number of vascular surgeries being performed, growing use of biological patches, need for minimally invasive surgeries and increasing product launches and research and development investments. On the contrary, scarcity of skilled professional, mishandling, decrease in carotid endarterectomy surgeries owing to low preference are factors that may restrict the growth of the vascular patches market.

Key Players

Vascular patches market players are include Baxter International Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Labcor Laboratórios Ltda (Brazil), Admedus (Australia), CryoLife, Inc. (U.S.), W. L. Gore & Associates, Inc. (US), LeMaitre Vascular, Inc. (U.S.), Maquet (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), C.R. Bard, Inc. (U.S.) and others.

Market Segmentation

MRFR report provides an extensive segmental analysis of the vascular patches market on the basis of application, material and end-user.

Based on material, it is segmented into synthetic vascular patches and biologic vascular patches. Of these, the biologic vascular patches will have the maximum share in the market over the predicted years followed by synthetic vascular patches that will grow at the fastest pace.

Based on application, the vascular patches market is segmented into open repair of abdominal aortic aneurysms vascular bypass surgery and carotid endarterectomy. Of these, carotid endarterectomy will dominate the market followed by open repair of abdominal aortic aneurysms vascular bypass surgery which will grow at the fastest rate.

Based on end-user, it is segmented into ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will rule the market followed by ambulatory surgical centers that will grow at the fastest pace.

Regional Analysis

By region, the vascular patches market insights covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will domineer the market over the predicted years and is expected to expand at a substantial CAGR. The increasing occurrence of cardiovascular issues in Canada and the US, growing population and increasing per capita healthcare spending will boost the market growth in this region. Also, the rapid uptake of latest devices and technologies in the surgical procedure and the presence of key manufacturers is again boosting the market growth. The vascular patches market in Europe will have the second major share due to the resurging economy, growing awareness regarding vascular patches and procedure advancements and increasing per capita healthcare expenses. The vascular patches market in the APAC region will grow at the fastest pace over the predicted years owing to growing healthcare sector in India and China, increasing geriatric populace, growing awareness regarding healthcare and rising incidence of people suffering from various chronic coronary diseases.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Respiratory Therapeutic Devices Market Players, Segmentation & Analysis by Recent Trends

Market Highlights 

The Respiratory Therapeutic Devices Market Size is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. 

Respiratory therapeutic devices are used in the treatment, management, and control of cardiopulmonary diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others. Increasing prevalence of asthma drives the market along with increasing per capita healthcare expenditure. According to the World Health Organization in 2017, approximately 235 million people have asthma. Moreover, it was estimated that in 2015, the diseases killed approximately 383 million patients around the globe. However, the market growth during the forecast period is likely to hamper due to low per capita income in the developing economies and lack of awareness.

Key Players

Global Respiratory Therapeutic Devices Market Players are

 

Masimo. (U.S.),

BD. (U.S.),

Smiths Group Plc. (U.S.),

F. Hoffmann-La Roche Ltd (Europe),

Bayer AG (Europe),

Rotech Healthcare Inc. (U.S.),

Chart Industries (U.S.),

Acare Technology (Asia Pacific), and

others.

Segmentation

The global respiratory therapeutic devices market is segmented on the basis of product, technology, application, and end users.

On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.

On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others. 

Regional Analysis

The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 

Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900. 

Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region. 

On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013              

 

Laboratory Information Systems Market Insights Analysis By Segmentations, Key Players & Regional Analysis

Market Scenario

The global laboratory information systems size is projected to grow USD 3.8694 billion by 2030 at CAGR of 9.50% during the forecast period 2023-2030, predicts Market Research Future (MRFR). There are several practice applications of an LIS that improve the day-to-day operations of a medical laboratory, along with prevention of medical errors. A busy medical laboratory having many patients on a regular basis encounter difficulty in keeping all the patients’ information organized. Thus, an LIS system comes in handy, as it helps keep all this information organized, which is vitally important for a medical lab to run smoothly. Apart from this, rising integration of LIS and Electronic Health Record (EHR) and demand for quality and precision diagnosis are majorly supplementing the market growth globally. Moreover, increasing penetration of mobile applications in healthcare solutions coupled with growing popularity of cloud-based laboratory information system testifies for the market progress that has taken place in the past few years.

On the flip side, lack of skilled information technology (IT) professionals in the healthcare industry tames the flow of the progressing market. However, an array of opportunities stemming from emerging regions along with the consistently growing adoption of LIS are proof enough that the global market is en-route to brighter future prospects. Also noteworthy are few trends that bestow the global market with the required push, including proliferation of smartphones, point-of-care devices and e-services in the healthcare industry which significantly shape the market dynamics. Also, immense demand from patients for technological solutions for more convenient health testing, and monitoring is growing. This leads to global market players taking notice of the opportunities that crop up and indulge in strategic activities such as product launches. For instance, in the year 2014, Thermo Fisher launched a new ultracentrifuge which combines speed with safety and ergonomics that allows researchers to protect samples easily while also achieving reliable and consistent results.

Key Players

global laboratory information systems market players include   Cerner Corporation, Recent Developments, Eclipsys Corporation, Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc., LabVantage Solutions Inc., LabWare Inc., McKesson Corporation, Medical Information Technology Inc., and others.

The Cerner EHR project is thriving as the U.S. Department of Defense increases its budget by about USD 1.2 billion. The additional funds will support the added services to maintain a standard EHR between the Department of Veterans Affairs and the U.S. Coast Guard. The EHR when integrated with laboratory information system, turns highly efficient, which leads to increased productivity and also reduced probability of errors. Cerner is an established company in the global LIS market that understands this fact and makes use of every opportunity to enhance its products to cater to various customer needs.

Market Segmentation

The laboratory information systems lis is segmented on the basis of application, components, and delivery.

By applications, the market is segmented based on clinical LIS, drug discovery LIS, and industrial LIS. The clinical application of LIS holds the largest market share as using LIS software involves more productivity and less paperwork, enhanced patient safety, and improved turn-around time.

By components, the market is segmented based on software, hardware, and services. Among these, the software segment accounts for the majority of the global LIS market due to increasing product enhancements and advent of innovative LIS software systems which ensures the smooth running of the healthcare department.

By delivery, the market is segmented on the basis of web-based, on-premise and cloud-based. Among these, cloud-based LIS software is highly popular as it offers various benefits such as cost savings, high security, flexibility, mobility and quality control.

Regional Analysis

By region, the global laboratory information systems market insights is segmented on the basis of North America, Europe, Asia Pacific and the Rest of the World (RoW).

The joint market share combining North America and Europe was more than 75% of the global total market size in 2014. However, North America has currently secured the top position claiming the largest market share. This stupendous growth can be attributed to increasing cases of fatal diseases and subsequent diagnostic and treatment needs. Moreover, high disposable income and strong economy also help augment the market growth in the region. Furthermore, increasing business opportunities for healthcare service providers along with growing demand for automated instruments rising in laboratories has majorly triggered the market growth in the region.

On the other hand, the Europe LIS market is estimated to grow tremendously during the forecast period, due to massive investment by healthcare IT players and a barrage of players trying to enter the regional market and establish themselves. Moreover, thriving healthcare industry and sophisticated medical infrastructure also play a major role in the growth of the regional market.

The Asia-marked Pacific is also presumed to grow at a significant pace throughout the forecast period. This growth is due to increased infectious diseases, significant increase in healthcare expenditure and advancements in healthcare IT sector. The market growth in the region is also aided by growing need for enhancing the efficiency of medical laboratories, growing demand for error-free diagnosis and increasing integration of information system with laboratories.

The rising aging population and increasing cases of fatal diseases in the regions of Middle East and Africa have propelled the market growth in the region. Also, the market in the region is highly fragmented, and the regional market players used various strategies such as product launches, expansions, and joint ventures to increase their footprint in the region. This gives a significant push to the market and will continue to do so in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Magnetic Resonance Imaging Systems Market : A Comprehensive Overview of the Current Trends

 

Market Scope

The Magnetic Resonance Imaging Systems Market Size is expected to reach USD 5,100 Million by 2030 at 7.30% CAGR during the forecast period 2022-2030.

We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

Top Market Firms

Hitachi,

Siemens AG,

Canon Medical Systems,

Xingaoyi,

Philips,

Toshiba Corporation,

Aurora Imaging Technologies, Inc.,

GE Healthcare,

Toshiba Corporation,

are among some of the top Magnetic Resonance Imaging Systems Market Players listed in the MRFR study.

Market Segmentation

The Global Magnetic Resonance Imaging Systems Market Report has been considered for type, field strength, disease application and end user.

Taking into account type, the market primarily caters to closed MRI, open MRI, wide-bore MRI and standard bore MRI.

Depending on field strength, the key segments can be very-high-field MRI systems, 1.5t MRI systems, high-field MRI systems, low-to-mid-field MRI systems, 3t MRI systems, and others.

Considering the disease application, the segments include cardiovascular MRI, brain and neurological MRI, spine and musculoskeletal MRI, breast MRI, pelvic and abdominal MRI, and others

With respect to end user, the market has been split into hospitals and clinics, diagnostic imaging centers, pharmaceutical &biotechnology companies and research laboratories.

Top Drivers and Main Barriers

Cutting edge technologies and intensive Magnetic Resonance Imaging Systems Market Research have resulted in the introduction of multiple advanced magnetic resonance imaging equipment that helps patients have longer and healthier lives. Magnetic resonance imaging technology is a diagnostic system that obtains information from the body’s interior and is extensively used in additional technical applications. A magnetic resonance imaging procedure helps create a 3D image of either the object or the patient that is being studied, without causing any hurt and without the use of ionizing radiation. With the substantial growth in the number of disorders related to neurology, spine, cardiovascular, orthopedic, neck and head, prostate and abdominal, the demand for advanced magnetic resonance imaging equipment has surged exponentially worldwide.

Magnetic Resonance Imaging Systems Market Overview and Analysis By Type (Open MRI and Close MRI), Field Strength (High-Field MRI Systems), Disease Application (Brain and Neurological MRI), and by End-Users (Hospitals & Clinics) - Forecast Till 2030

Regional Outlook

Europe, Americas, MEA or Middle East and Africa and Asia Pacific or APAC are the top Magnetic Resonance Imaging Systems Market.

America remains the market leader, observing the highest demand and use of magnetic resonance imaging (MRI) systems. The key reasons responsible for the region’s lead in the global market could be the heavy burden of neurological, ophthalmic and cardiovascular disorders, especially among the geriatric populace. Rigorous government efforts as well as spending on researches pertaining to medical devices along with the escalating demand for correct diagnosis also benefit the regional market. Substantial awareness level regarding the toxic effects of using radiation imaging, and the huge numbers of pharmaceutical firms present in the region also induces significant market growth.

APAC is touted to witness the fastest growth, as it demonstrates maximum growth possibilities. The massive patient pool, willingness to adopt latest healthcare technologies and government initiatives to improve the healthcare infrastructure are some of the top growth boosters. The improving insurance schemes and policies for patients, cheap costs of clinical trials and the intensive researches conducted by the prominent vendors in the region also enhance the market size. The rising number of players setting up their manufacturing units in Singapore, Japan, China, Australia and Korea also boosts the APAC market’s growth potential.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Meningococcal Vaccines Market By Business Top Key Players, Growth & Trend to 2032

 

Market Forecast

Meningococcal Vaccines Market size is projected to be worth USD 6.80 billion by 2032, registering a CAGR of 7.3% during the forecast period 2023 – 2032.

Market Synopsis

Meningococcal meningitis is a bacterial infection caused by Neisseria meningitides. Disease incidence is high in West and Central Africa, where historically, serogroup A has been the most important cause of disease. More recently, meningitis outbreaks have gradually been associated with serogroup C, and to a lesser extent, serogroup W.

The meningococcal vaccines market is complex and diverse, with regional variations in serogroup distribution with substantial use outside routine immunization. The vaccine has approximately 29 marketed products targeting various combinations of the six serogroups (A, B, C, W, X, Y).

Market Influencer

Without an increase in production, the existing supply of conjugate MenACWY will be inadequate to meet the demand generated by the rising incidence of serogroups C and W, and the low availability of polysaccharide vaccines. Further, several multivalent, conjugate vaccines by Chinese and Indian manufacturers are in the pipeline, and, if prequalified they will be registered for use in many geographies. Moreover, if they are made available at acceptable prices it could increase global demand in Meningococcal Vaccines Market Trends.

Meningococcal Vaccines Market Segmentation

By treatment, the market is segmented into Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine.

Meningococcal A conjugate vaccine is significantly used in mass campaigns across affected regions like Africa. Since 2010, the vaccine has significantly decreased meningococcal disease incidence in the region. However, the demand for meningococcal A conjugate in the country remains uncertain given that national immunization program adoptions are based on the timing of Gavi funding decisions, the country’s readiness, and competing for vaccine introduction priorities.

In the polysaccharide segment, products such as MenACWY vaccines are in high demand. MenACWY vaccine is the most desirable combination, given its broader serotype coverage. MenACWY specifically has nine products that are available across polysaccharide and conjugate product segments, but conjugate products are suggested for use in routine immunization activities.

Moreover, the demand and supply of Subcap MenB vaccines is restricted to HICs and influenced by their acceptance into NIPs. Improved uptake of MenB vaccines is expected in the coming years but will likely be moderate and limited to high-income markets given the high price and competing interest of introducing MenACWY conjugate.

By end-user, the market is segmented into Hospital & Clinical, Research Laboratories, and Academic Institutes

Hospitals and clinics control the global meningococcal vaccines market. The high growth of hospitals and clinics segment is attributed to the increasing application of vaccines in these healthcare facilities in conjunction with the growing prevalence and incidence of the meningococcal disease.

Moreover, research laboratories and academic institutes take up the second-largest share due to the boost in research and development in the market.

By region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

In the global market, China is expected to have the largest market share, which accounts for approximately 35% of the global demand. This is primarily due to polysaccharide products, which currently comprise 84% of China’s demand. Chinese suppliers presently focus only on meeting the demand of the domestic market, but some of the manufacturers have indicated interest in the global market as well. The dynamic product pipeline with several multivalent conjugate products in development may trigger changes in the future supply mix of the Chinese market. Moreover, in China, non-routine use (excluding campaigns) accounts for an estimated 9 million doses in 2019, which may help to sustain the huge market share in the forecast period.

UNICEF foresees all 26 African countries in the meningitis belt, which have completed mass campaigns in 2016. In 2015, seven countries in the region were introduced with meningococcal A conjugate vaccine through their mass campaigns and targeted a population of 233 million. Further, during 2016-2018, UNICEF introduced meningococcal A conjugate vaccine in 26 countries. Ghana was the first country to be introduced with the vaccine into its RI schedule in 2016. Also, four other countries including Mali, Niger, Nigeria, and Sudan introduced the vaccine into RI programs in 2016.

Key Players

• Baxter international
• Pfizer Inc.
• Sanofi S.A.
• Novartis Pharmaceuticals Inc.
• JN-International Medical Corporation
• Serum Institute of India Ltd.
• GlaxoSmithKline
• BIO-MED
• OthersTop of Form

Bottom of Form

 Bottom of Form

Bottom of Form

Bottom of Form

Bottom of Form

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America